Viewing Study NCT00000750


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2025-12-30 @ 12:14 AM
Study NCT ID: NCT00000750
Status: COMPLETED
Last Update Posted: 2021-10-28
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module